Cold & Cough Remedies (Pharmacies) - Bangladesh

Revenue in the Cold & Cough Remedies market is projected to reach US$225.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 14.66%, resulting in a market volume of US$446.00m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$1.29 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Bangladesh has been experiencing significant growth in recent years.

Customer preferences: Customers in Bangladesh have shown a growing preference for over-the-counter cold and cough remedies purchased from pharmacies. This can be attributed to several factors, including the convenience of purchasing these products directly from pharmacies, the increasing awareness and knowledge about the effectiveness of these remedies, and the affordability of such products compared to prescription medications.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Bangladesh is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the potential side effects of synthetic medications and are opting for natural alternatives. This trend is driven by a growing interest in holistic health and wellness, as well as a preference for traditional remedies that have been used for generations. Another trend in the market is the rise of combination products that offer multiple benefits in a single medication. For example, cold and cough remedies that also provide relief from nasal congestion or sore throat are becoming increasingly popular. This trend is driven by the desire for convenience and efficiency, as customers prefer products that can address multiple symptoms simultaneously.

Local special circumstances: Bangladesh has a high population density, with a large number of people living in urban areas. This creates a favorable environment for the growth of the Cold & Cough Remedies (Pharmacies) market, as there is a higher demand for these products in densely populated areas where the risk of transmission of cold and cough viruses is higher. Additionally, the presence of a well-established pharmacy network across the country makes it easier for customers to access these remedies.

Underlying macroeconomic factors: The growing middle class in Bangladesh, along with increasing disposable income, has contributed to the growth of the Cold & Cough Remedies (Pharmacies) market. As more people are able to afford healthcare products, the demand for over-the-counter remedies has increased. Furthermore, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also played a role in driving the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Bangladesh is experiencing significant growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, the local special circumstances of high population density and a well-established pharmacy network, and the underlying macroeconomic factors of a growing middle class and government initiatives to improve healthcare access.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.